Krsnaa Diagnostics Limited

Informe acción NSEI:KRSNAA

Capitalización de mercado: ₹29.9b

Krsnaa Diagnostics Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Krsnaa Diagnostics ha aumentado sus beneficios a una tasa media anual de 7.2%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 28% anual. Los ingresos han ido creciendo a una tasa media de 17.5% al año. La rentabilidad financiera de Krsnaa Diagnostics es de 8.2%, y sus márgenes netos son de 10.2%.

Información clave

7.2%

Tasa de crecimiento de los beneficios

-8.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare 29.4%
Tasa de crecimiento de los ingresos17.5%
Rentabilidad financiera8.2%
Margen neto10.2%
Próxima actualización de resultados14 Feb 2025

Actualizaciones de resultados anteriores recientes

We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings

May 26
We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings

Recent updates

Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Sep 06
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Aug 23
Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50

Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 10
Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Aug 09
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50

Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors

Jul 05
Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors

Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return

Jun 16
Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return

We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings

May 26
We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings

Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?

Mar 14
Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?

Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 16
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models

Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Aug 31
Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Aug 17
Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75

Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)

Jun 03
Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)

Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 17
Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)

Feb 16
Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)

Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think

Nov 17
Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think

Desglose de ingresos y gastos

Cómo gana y gasta dinero Krsnaa Diagnostics. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NSEI:KRSNAA Ingresos, gastos y beneficios (INR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 246,8126921,9970
30 Jun 246,5036011,8200
31 Mar 246,1965681,8880
31 Dec 235,8665701,8440
30 Sep 235,4645771,7180
30 Jun 235,1386251,5250
31 Mar 234,8716211,6800
31 Dec 224,6216111,6900
30 Sep 224,5056381,7520
30 Jun 224,3586101,6560
31 Mar 224,5556841,7240
31 Dec 214,4313951,5180
31 Mar 213,9651,8491,4640
31 Dec 203,6941,3071,4410
31 Mar 202,584-1,1201,0600
31 Mar 192,092-6218770
31 Mar 181,076-6023720
31 Mar 17569-391300

Ingresos de calidad: KRSNAA tiene un alto nivel de ganancias no monetarias.

Margen de beneficios creciente: Los actuales márgenes de beneficio(10.2%) de KRSNAA son inferiores a los del año pasado (10.6%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: KRSNAA ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 7.2% al año.

Acelerando crecimiento: El crecimiento de los beneficios de KRSNAA en el último año (20%) supera su media de 5 años (7.2% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de KRSNAA en el último año (20%) no superó al de la industria Healthcare 33.3%.


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de KRSNAA (8.2%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado